• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Catalog Number 1804350-23
Device Problems Material Rupture (1546); Difficult or Delayed Activation (2577); Difficult to Advance (2920)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 02/28/2024
Event Type  Injury  
Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
 
Event Description
It was reported that the procedure was to treat a heavily calcified left anterior descending artery that is 90% stenosed.Previous stent was noted left main and in stent restenosis (isr) in the target lesion.Atherectomy was performed with a diamondback 360 coronary orbital atherectomy device (oad) in the isr.Pre-dilatation was performed and a 3.5x23mm xience skypoint stent delivery system (sds) was advanced; however, met resistance with anatomy.The stent deployed at 12 atmospheres; however, it was observed that it kept losing pressure.Therefore, once the sds was removed, the stent remained in place but was observed to not be fully expanded.A 1.5x20mm and 2.0x20mm balloons were used to fully expand the stent.Post dilatation was performed with 3.5x12mm balloon.Once the sds was removed from the anatomy it was inflated and a hole was noted on the sds balloon.There was no adverse patient sequela; however, the patient was not discharged untill the following day.No additional information was provided.
 
Manufacturer Narrative
A visual and functional inspection was performed on the returned device.The reported material rupture was confirmed.The reported difficult to advance and difficult/delayed reaction could not be evaluated as the exact anatomical conditions encountered by the device used during the procedure could not be replicated in the test laboratory.The lot history record (lhr) and corrective and preventive actions (capa) reviews were performed and revealed no indication of a product quality issue.Additionally, a review of the complaint history identified no similar incidents from this lot.The investigation determined the reported difficulties and subsequent unexpected medical intervention (additional therapy/non-surgical treatment) appear to be related to the operational context of the procedure, as it is likely that the xience skypoint interacted with heavily calcified, 90% stenosed lesion during advancement, as resistance was noted, causing the reported difficult to advance/position.Further interaction with the challenging anatomy likely contributed to the reported material rupture and observed leak/splash, ultimately causing the reported difficult/delayed activation.There is no indication of a product quality issue with respect to manufacture, design, or labeling.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key18936865
MDR Text Key338068949
Report Number2024168-2024-03514
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08717648233418
UDI-Public(01)08717648233418(17)260918(10)3092541
Combination Product (y/n)Y
Reporter Country CodeUS
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 04/26/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/19/2024
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Catalogue Number1804350-23
Device Lot Number3092541
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/07/2024
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/19/2024
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured09/19/2023
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention; Hospitalization;
Patient Age64 YR
Patient SexFemale
Patient Weight89 KG
-
-